PARP inhibition synergizes with anti-CTLA-4 immune therapy to promote rejection of peritoneal tumors in mouse models of ovarian cancer

Adams, Sarah

285 - Poster Session A
PARP inhibition synergizes with anti-CTLA-4 immune therapy to promote rejection of peritoneal tumors in mouse models of ovarian cancer

Saturday, March 22, 2014: 10:25 AM

West Exhibit Hall (Tampa Convention Center)

T. Higuchi¹, D. Flies¹, G. M. Mantia-Smaldone², P. L. Ronner³, J. Alldredge¹, S. Orsulic⁴ and S. F. Adams¹
¹University of New Mexico, Albuquerque, NM, ²Fox Chase Cancer Center, Philadelphia, PA, ³Carnegie Mellon University, Pittsburgh, PA, ⁴Cedars-Sinai Medical Center, Los Angeles, CA

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

285 - Poster Session A
PARP inhibition synergizes with anti-CTLA-4 immune therapy to promote rejection of peritoneal tumors in mouse models of ovarian cancer

285 - Poster Session A PARP inhibition synergizes with anti-CTLA-4 immune therapy to promote rejection of peritoneal tumors in mouse models of ovarian cancer

285 - Poster Session A
PARP inhibition synergizes with anti-CTLA-4 immune therapy to promote rejection of peritoneal tumors in mouse models of ovarian cancer